focus -WSS

focus

author：comprehensive 2025-08-23 08:57:22 - browse：778

Boston Scientific headquarters -- Health coverage from STAT — Boston Scientific is growing its urology portfolio with the Axonics acquisition. Steven Senne/AP

Boston Scientific said it will buy Axonics, a device company treating urinary and bowel disorders, on Monday. The deal is worth $3.7 billion.

It’s the first billion-dollar medical device deal of 2024 — a rare occurrence in 2023, which saw just a handful of medtech acquisitions reaching the billion threshold. Boston Scientific said it expects to close the deal in the first half of this year. Axonics’ stock increased by 20% in light of the news; Boston Scientific’s dropped slightly.

Boston Scientific has acquired companies across all medtech sectors in the past year. The device maker bought Apollo Endosurgery, a company selling surgical tools to combat obesity, for $615 million in 2023. In September of 2023, Boston Scientific bought pain relief company Relievant for $850 million.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： Pandemic and All Hazards Preparedness Act needs lean update

Wikipedia

WSS

A public health expert passes on football's full body collisions for youths

Inside the rise of 'mukbang' eating videos

Canadian wildfire dangers should prompt more proactive mitigation from government: Experts

FDA approves first new drug developed for postpartum depression

Biden’s NIH nominee is languishing in Congress

US sending controversial cluster munitions to Ukraine until other ammo is ready: Kirby

focus

focus

entertainment

Affirmative action in medical school literally saved lives

Over 1,300 arrested in France in 4th night of protests over fatal police shooting of teen Nahel M.

Hollywood unions extend contract negotiations for actors

How to fix the rural physician shortage in the U.S.

In Memoriam: Notable people who died in 2023

Bispecific antibodies are next new thing in cancer immunotherapy

Alkermes shareholders re

Tulsa Race Massacre survivors and attorneys respond to dismissal of lawsuit

As demand for Covid shots wanes, Moderna seeks its next success

Swim instructor mom warns parents not to buy blue swimsuits for kids

Wikipedia

Novo: Oral version of Ozempic leads to 15% weight loss

Xenotransplantation trials will require adjusting expectations, experts say

Bispecific antibodies are next new thing in cancer immunotherapy

Sea level rise could wash away turtle breeding grounds around the world, researchers say

Judge agrees to delay next hearing in Trump classified documents case

Pandemic and All Hazards Preparedness Act needs lean update

leisure time

Wikipedia

entertainment

hotspot